Drug Profile
Research programme: translation initiation factor inhibitors - Egenix
Alternative Names: 1181; 4EGI-1Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Egenix
- Class Small molecules
- Mechanism of Action Eukaryotic initiation factor 4E inhibitors; Eukaryotic initiation factor-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 11 Jun 2012 Preclinical trials in Cancer in USA (unspecified route)